We are a target discovery and gene editing company utilizing artificial intelligence and our proprietary neural network platform with a therapeutic focus on immuno-oncology. Our proprietary target discovery engine is called “Diamond.”

Diamond is a computational platform and a neural network that can identify new cancer immunological targets for T cells and B cells. Diamond is an artificial intelligence bioinformatic approach that can identify novel surface tumor targets. It uses public and proprietary samples and can expand into the tumor target space.